Familial Risk for Major Depression is Associated with Lower Striatal 5-HT₄ Receptor Binding

Overview

Journal Int J Neuropsychopharmacol

Publisher Oxford University Press

Specialty Psychiatry

Date 2014 Dec 19

PMID 25522384

Citations 24

Authors

Karine Madsen

Eva Torstensen

Klaus K Holst

Mette E Haahr

Ulla Knorr

Vibe G Frokjaer

Malene Brandt-Larsen

Pernille Iversen

Patrick M Fisher

Gitte M Knudsen

Affiliations

Soon will be listed here.

Abstract

Background: The 5-HT4 receptor provides a novel potential target for antidepressant treatment. No studies exist to elucidate the 5-HT4 receptor's in vivo distribution in the depressed state or in populations that may display trait markers for major depression disorder (MDD). The aim of this study was to determine whether familial risk for MDD is associated with cerebral 5-HT4 receptor binding as measured with [(11)C]SB207145 brain PET imaging. Familial risk is the most potent risk factor of MDD.

Methods: We studied 57 healthy individuals (mean age 36 yrs, range 20-86; 21 women), 26 of which had first-degree relatives treated for MDD.

Results: We found that having a family history of MDD was associated with lower striatal 5-HT4 receptor binding (p = 0.038; in individuals below 40 years, p = 0.013). Further, we found evidence for a "risk-dose effect" on 5-HT4 receptor binding, since the number of first-degree relatives with a history of MDD binding correlated negatively with 5-HT4 receptor binding in both the striatum (p = 0.001) and limbic regions (p = 0.012).

Conclusions: Our data suggest that the 5-HT4 receptor is involved in the neurobiological mechanism underlying familial risk for depression, and that lower striatal 5-HT4 receptor binding is associated with increased risk for developing MDD. The finding is intriguing considering that the 5-HT4 receptor has been suggested to be an effective target for antidepressant treatment.

Citing Articles

Effects of a 5-HT receptor antagonist in the caudate nucleus on the performance of macaques in a delayed reward task.

Hori Y, Iwaoki H, Mimura K, Nagai Y, Higuchi M, Minamimoto T Sci Rep. 2024; 14(1):19619.

PMID: 39179718 PMC: 11344137. DOI: 10.1038/s41598-024-70414-6.

No association between peripheral serotonin-gene-related DNA methylation and brain serotonin neurotransmission in the healthy and depressed state.

Bruzzone S, Ozenne B, Fisher P, Ortega G, Jensen P, Dam V Clin Epigenetics. 2024; 16(1):71.

PMID: 38802956 PMC: 11131311. DOI: 10.1186/s13148-024-01678-y.

The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders.

Sgambato V Int J Mol Sci. 2024; 25(10).

PMID: 38791281 PMC: 11121119. DOI: 10.3390/ijms25105245.

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia.

Cirillo R, Duperrier S, Parekh P, Millot M, Li Q, Thiolat M J Parkinsons Dis. 2024; 14(2):261-267.

PMID: 38339940 PMC: 10977406. DOI: 10.3233/JPD-230331.

Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders.

Mitroshina E, Marasanova E, Vedunova M Int J Mol Sci. 2023; 24(22).

PMID: 38003611 PMC: 10671093. DOI: 10.3390/ijms242216416.

References

Haahr M, Fisher P, Jensen C, Frokjaer V, Mahon B, Madsen K . Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study. Mol Psychiatry. 2013; 19(4):427-32. DOI: 10.1038/mp.2013.147. View

Haahr M, Rasmussen P, Madsen K, Marner L, Ratner C, Gillings N . Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry. Neuroimage. 2012; 61(4):884-8. DOI: 10.1016/j.neuroimage.2012.03.050. View

Caspi A, Sugden K, Moffitt T, Taylor A, Craig I, Harrington H . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003; 301(5631):386-9. DOI: 10.1126/science.1083968. View

Robinson O, Cools R, Carlisi C, Sahakian B, Drevets W . Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry. 2012; 169(2):152-9. PMC: 5648982. DOI: 10.1176/appi.ajp.2011.11010137. View

Svarer C, Madsen K, Hasselbalch S, Pinborg L, Haugbol S, Frokjaer V . MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005; 24(4):969-79. DOI: 10.1016/j.neuroimage.2004.10.017. View

King M, Marsden C, Fone K . A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci. 2008; 29(9):482-92. DOI: 10.1016/j.tips.2008.07.001. View

Feder A, Skipper J, Blair J, Buchholz K, Mathew S, Schwarz M . Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biol Psychiatry. 2011; 69(8):804-7. PMC: 3941748. DOI: 10.1016/j.biopsych.2010.12.033. View

Kalbitzer J, Erritzoe D, Holst K, Nielsen F, Marner L, Lehel S . Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes. Biol Psychiatry. 2010; 67(11):1033-9. DOI: 10.1016/j.biopsych.2009.11.027. View

Pizzagalli D, Holmes A, Dillon D, Goetz E, Birk J, Bogdan R . Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry. 2009; 166(6):702-10. PMC: 2735451. DOI: 10.1176/appi.ajp.2008.08081201. View

10.

Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Navarro M . Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology. 2004; 49(4):189-95. DOI: 10.1159/000077365. View

11.

Levinson D . The genetics of depression: a review. Biol Psychiatry. 2005; 60(2):84-92. DOI: 10.1016/j.biopsych.2005.08.024. View

12.

Olsen L, Jensen D, Noerholm V, Martiny K, Bech P . The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med. 2003; 33(2):351-6. DOI: 10.1017/s0033291702006724. View

13.

Rice J, Reich T, Bucholz K, Neuman R, Fishman R, Rochberg N . Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res. 1995; 19(4):1018-23. DOI: 10.1111/j.1530-0277.1995.tb00983.x. View

14.

Woods R, Cherry S, Mazziotta J . Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992; 16(4):620-33. DOI: 10.1097/00004728-199207000-00024. View

15.

Stoy M, Schlagenhauf F, Sterzer P, Bermpohl F, Hagele C, Suchotzki K . Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol. 2011; 26(5):677-88. DOI: 10.1177/0269881111416686. View

16.

Miller J, Brennan K, Ogden T, Oquendo M, Sullivan G, Mann J . Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology. 2009; 34(10):2275-84. PMC: 2760406. DOI: 10.1038/npp.2009.54. View

17.

Marner L, Gillings N, Comley R, Baare W, Rabiner E, Wilson A . Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo. J Nucl Med. 2009; 50(6):900-8. DOI: 10.2967/jnumed.108.058552. View

18.

Vidal R, Castro E, Pilar-Cuellar F, Pascual-Brazo J, Diaz A, Rojo M . Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?. Curr Pharm Des. 2013; 20(23):3751-62. DOI: 10.2174/13816128113196660734. View

19.

Mendez-David I, David D, Darcet F, Wu M, Kerdine-Romer S, Gardier A . Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology. 2013; 39(6):1366-78. PMC: 3988540. DOI: 10.1038/npp.2013.332. View

20.

Bech P, Rasmussen N, Olsen L, Noerholm V, Abildgaard W . The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord. 2001; 66(2-3):159-64. DOI: 10.1016/s0165-0327(00)00309-8. View